AFP and hepatocellular carcinoma: A prospective study included 189 HBV-related HCC patients between 1995-2008 found that patients with preoperative AFP in the first quintile (1.4-4.1 ng/mL) had better overall survival (OS) and disease-free survival (DFS) than the other four groups (9).